Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. 3-o-ethyl Ascorbic Acid
2. 3-o-ethylascorbic Acid
3. Vitamin C Ethyl
1. 86404-04-8
2. 3-o-ethyl Ascorbic Acid
3. 3-o-ethylascorbic Acid
4. L-ascorbic Acid, 3-o-ethyl-
5. Vitamin C Ethyl
6. (2r)-2-[(1s)-1,2-dihydroxyethyl]-3-ethoxy-4-hydroxy-2h-furan-5-one
7. (r)-5-((s)-1,2-dihydroxyethyl)-4-ethoxy-3-hydroxyfuran-2(5h)-one
8. 6mw60cb71p
9. Ccris 7479
10. 3-o-ethyl-l-ascorbicacid
11. Unii-6mw60cb71p
12. Mfcd09261382
13. Activita C
14. 5-(1,2-dihydroxy-ethyl)-4-ethoxy-3-hydroxy-5h-furan-2-one
15. 3-o-ethyl-ascorbic Acid
16. Ec 617-849-3
17. 3-o-ethyl Ascorbate
18. Schembl352408
19. Corum 9515
20. Dtxsid8020595
21. Chebi:189226
22. Act05052
23. Zinc29390603
24. (5r)-5-((1s)-1,2-dihydroxyethyl)-4-ethoxy-3-hydroxy-5h-furan-2-one
25. (5r)-5-[(1s)-1,2-dihydroxyethyl]-4-ethoxy-3-hydroxyfuran-2(5h)-one
26. (5r,1's)-5-(1,2-dihydroxy-ethyl)-4-ethoxy-3-hydroxy-5h-furan-2-one
27. Akos015920304
28. Cs-w003607
29. Gs-4098
30. Hy-w003607
31. 3-o-ethyl-l-ascorbic Acid, Aldrichcpr
32. 3-o-ethyl Ascorbic Acid [inci]
33. L-ascorbic Acid 3-o-ethyl Ether
34. 404e048
35. Q-102493
36. Q27265176
37. (2r)-2-[(1s)-1,2-dihydroxyethyl]-3-ethoxy-4-hydroxy-2h-uran-5-one
38. (5r,1's)-5-(1,2-dihydroxy-ethyl)-4-ethoxy-3- Hydroxy-5h-furan-2-one
39. (5r)-5-[(1s)-1,2-dihydroxyethyl]-4-ethoxy-3-hydroxy-2,5-dihydrofuran-2-one
40. (5r)-5-[(1s)-1,2-dihydroxyethyl]-4-ethoxy-3-hydroxy-5h-furan-2-one;3-o-ethyl-l-ascorbic Acid
| Molecular Weight | 204.18 g/mol |
|---|---|
| Molecular Formula | C8H12O6 |
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 204.06338810 g/mol |
| Monoisotopic Mass | 204.06338810 g/mol |
| Topological Polar Surface Area | 96.2 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 259 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
47
PharmaCompass offers a list of 3-O-Ethyl Ascorbic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 3-O-Ethyl Ascorbic Acid manufacturer or 3-O-Ethyl Ascorbic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 3-O-Ethyl Ascorbic Acid manufacturer or 3-O-Ethyl Ascorbic Acid supplier.
PharmaCompass also assists you with knowing the 3-O-Ethyl Ascorbic Acid API Price utilized in the formulation of products. 3-O-Ethyl Ascorbic Acid API Price is not always fixed or binding as the 3-O-Ethyl Ascorbic Acid Price is obtained through a variety of data sources. The 3-O-Ethyl Ascorbic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EC 617-849-3 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EC 617-849-3, including repackagers and relabelers. The FDA regulates EC 617-849-3 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EC 617-849-3 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of EC 617-849-3 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A EC 617-849-3 supplier is an individual or a company that provides EC 617-849-3 active pharmaceutical ingredient (API) or EC 617-849-3 finished formulations upon request. The EC 617-849-3 suppliers may include EC 617-849-3 API manufacturers, exporters, distributors and traders.
click here to find a list of EC 617-849-3 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
EC 617-849-3 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EC 617-849-3 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EC 617-849-3 GMP manufacturer or EC 617-849-3 GMP API supplier for your needs.
A EC 617-849-3 CoA (Certificate of Analysis) is a formal document that attests to EC 617-849-3's compliance with EC 617-849-3 specifications and serves as a tool for batch-level quality control.
EC 617-849-3 CoA mostly includes findings from lab analyses of a specific batch. For each EC 617-849-3 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EC 617-849-3 may be tested according to a variety of international standards, such as European Pharmacopoeia (EC 617-849-3 EP), EC 617-849-3 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EC 617-849-3 USP).
